Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Spriggs

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Journal of Virology|October 1, 1986
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing techniqueR Bassel-Duby, D R Spriggs, K L Tyler, et al.
Blood|August 1, 1988
Phospholipase C activates protein kinase C and induces monocytic differentiation of HL-60 cellsR M Stone, B L Weber, D R Spriggs, et al.
The Journal of Experimental Medicine|June 1, 1989
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gammaP Brouckaert, D R Spriggs, G Demetri, et al.
Cancer Research|November 1, 1988
Effects of tiazofurin on protooncogene expression during HL-60 cell differentiationS M Kharbanda, M L Sherman, D R Spriggs, et al.
Leukemia|May 1, 1988
Prolonged high dose ARA-C infusions in acute leukemiaD R Spriggs, G Robbins, K Arthur, et al.
European Journal of Gynaecological Oncology|September 4, 1999
Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinomaD S Chi, R J Waltzman, R R Barakat, et al.
The Journal of Clinical Investigation|August 1, 1983
Specific plasma membrane receptors for reovirus on rat pituitary cells in cultureE Maratos-Flier, C R Kahn, D R Spriggs, et al.
The Journal of Clinical Investigation|February 1, 1988
Tumor necrosis factor expression in human epithelial tumor cell linesD R Spriggs, K Imamura, C Rodriguez, et al.
Gynecologic Oncology|September 28, 2000
Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second lookS Makhija, P Sabbatini, C Aghajanian, et al.
Cancer Research|November 1, 1986
Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological studyD R Spriggs, E Stopa, R J Mayer, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Journal of Virology|October 1, 1986
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing techniqueR Bassel-Duby, D R Spriggs, K L Tyler, et al.
Blood|August 1, 1988
Phospholipase C activates protein kinase C and induces monocytic differentiation of HL-60 cellsR M Stone, B L Weber, D R Spriggs, et al.
The Journal of Experimental Medicine|June 1, 1989
Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gammaP Brouckaert, D R Spriggs, G Demetri, et al.
Cancer Research|November 1, 1988
Effects of tiazofurin on protooncogene expression during HL-60 cell differentiationS M Kharbanda, M L Sherman, D R Spriggs, et al.
Leukemia|May 1, 1988
Prolonged high dose ARA-C infusions in acute leukemiaD R Spriggs, G Robbins, K Arthur, et al.
European Journal of Gynaecological Oncology|September 4, 1999
Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinomaD S Chi, R J Waltzman, R R Barakat, et al.
The Journal of Clinical Investigation|August 1, 1983
Specific plasma membrane receptors for reovirus on rat pituitary cells in cultureE Maratos-Flier, C R Kahn, D R Spriggs, et al.
The Journal of Clinical Investigation|February 1, 1988
Tumor necrosis factor expression in human epithelial tumor cell linesD R Spriggs, K Imamura, C Rodriguez, et al.
Gynecologic Oncology|September 28, 2000
Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second lookS Makhija, P Sabbatini, C Aghajanian, et al.
Cancer Research|November 1, 1986
Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological studyD R Spriggs, E Stopa, R J Mayer, et al.
Pageof 10